BOCA RATON, FL / ACCESS Newswire / November 13, 2025 / Newsmax Inc. (NYSE:NMAX) ("Newsmax" or the "Company") today announced ...

Pre-NDA meeting with FDA to discuss brilaroxazine’s path to approval for schizophrenia planned in Q4 2025 – – Potential NDA submission for ...

Aardvark has aligned with the FDA to reduce the minimum age of eligibility from 13 to 10 years old for pediatric patients in HERO, the Phase 3 ...

Trailing twelve-month (TTM) 1 income from continuing operations of $30.5 million, divided by 47.6 million shares outstanding as of September 30, equates to earnings per share of $0.64. This represents ...

Announced completion of dose exploration portion of ORIC-944 Phase 1b clinical trial and presented data that continues to demonstrate potential best-in-class efficacy and safety.

As with most ingenious ideas, it seems so obvious in retrospect. “How come no one has done this before? Thought of this ...

President Donald Trump has signed a government funding bill, ending a record 43-day shutdown that magnified partisan ...

BYU President Shane Reese and Advancement Vice President Keith Vorkink join the first episode of the Deseret Voices podcast ...

Understanding Medicare enrollment, FEHB coverage, and TRICARE can help retirees avoid penalties, save money and coordinate ...

Q3 2025 Earnings Call November 13, 2025 8:00 AM ESTCompany ParticipantsMike MoyerScott Plesha - CEO, President ...

Water managers from the seven states that share the Colorado River have blown a deadline given to them by the federal ...

Nationwide, high and improving graduation rates often do not align with other measures, as was the case in the California ...